Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Biochemical Assay from US Patent US20240025884: "COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF"
Assay data:498 Active, 503 Activity ≤ 1 µM, 503 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
SMARCA2 Bromodomain Binary and Ternary Binding Assay from US Patent US20240018158: "BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE"
Assay data:5 Active, 5 Activity ≤ 1 µM, 5 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
HTRF Assay from US Patent US20240018153: "BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF"
Assay data:13 Active, 13 Activity ≤ 1 µM, 13 Tested
In Vitro Activity Against CBP from US Patent US20240016795: "BROMODOMAIN INHIBITORS FOR ANDROGEN RECEPTOR-DRIVEN CANCERS"
Assay data:4 Active, 4 Activity ≤ 1 µM, 4 Tested
Biochemical Assay from US Patent US20240002365: "PYRIDAZINE AND 1,2,4-TRIAZINE DERIVATIVES AS FGFR KINASE INHIBITORS"
Assay data:3 Active, 1 Activity ≤ 1 nM, 3 Activity ≤ 1 µM, 3 Tested
Kinase Activity Assay from US Patent US20230416271: "HETEROARYLQUINAZOLINE COMPOUNDS AS PROTEIN KINASE INHIBITORS"
Assay data:50 Active, 26 Activity ≤ 1 nM, 51 Activity ≤ 1 µM, 51 Tested
Biochemical Kinase Assay from US Patent US11840535: "Alkynyl(hetero)aromatic compound for inhibiting protein kinase activity"
Assay data:25 Active, 25 Activity ≤ 1 µM, 25 Tested
Biochemical Assay for GCN2 from US Patent US20230382915: "GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF"
Assay data:30 Active, 24 Activity ≤ 1 µM, 30 Tested
CSNK1A1 Assay 1 from US Patent US20230365554: "SUBSTITUTED PYRROLO-PYRIDINONE DERIVATIVES AND THERAPEUTIC USES THEREOF"
CSNK1A1 Assay 2 from US Patent US20230365554: "SUBSTITUTED PYRROLO-PYRIDINONE DERIVATIVES AND THERAPEUTIC USES THEREOF"
Assay data:34 Active, 34 Activity ≤ 1 µM, 34 Tested
EZH2 Enzyme Activity Assay from US Patent US20230365541: "INHIBITOR OF ENHANCER OF ZESTE HOMOLOGUE 2, AND USE THEREOF"
Assay data:64 Active, 64 Activity ≤ 1 nM, 64 Activity ≤ 1 µM, 64 Tested
Enzymatic ATM Assay from US Patent US20230348462: "IMIDAZO[4,5-C]QUINOLINE COMPOUNDS AND THEIR USE AS ATM KINASE INHIBITORS"
Assay data:27 Active, 17 Activity ≤ 1 nM, 27 Activity ≤ 1 µM, 27 Tested
Inhibition of SIK; Abl and Src Kinases by Other Kinase Inhibitor from US Patent US20230348453: "HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF"
Assay data:29 Active, 29 Activity ≤ 1 µM, 29 Tested
C-abl Kinase Assay from US Patent US20230339978: "COMPOUNDS FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISORDERS"
Assay data:29 Active, 2 Activity ≤ 1 nM, 29 Activity ≤ 1 µM, 29 Tested
CSNK1A1 Inhibitory Activity Asaay 1 from US Patent US20230339939: "SUBSTITUTED 1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS AND METHODS OF USE THEREOF"
CSNK1A1 High ATP Assay from US Patent US20230339939: "SUBSTITUTED 1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS AND METHODS OF USE THEREOF"
Assay data:49 Active, 46 Activity ≤ 1 µM, 49 Tested
CSNK1A1 Inhibitory activity Assay 2 from US Patent US20230339939: "SUBSTITUTED 1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS AND METHODS OF USE THEREOF"
Assay data:51 Active, 4 Activity ≤ 1 nM, 51 Activity ≤ 1 µM, 51 Tested
USP7 Assay B (Ubitquin-Rhodamine110 Assay) from US Patent US20230338337: "BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS"
Assay data:206 Active, 18 Activity ≤ 1 nM, 206 Activity ≤ 1 µM, 206 Tested
USP7 Assay A (Ubitquin-Rhodamine110 Assay) from US Patent US20230338337: "BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS"
Assay data:57 Active, 5 Activity ≤ 1 nM, 57 Activity ≤ 1 µM, 58 Tested
USP7 Assay B (Ubitquin-Rhodamine110 Assay) from US Patent US11795171: "Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors"
Assay data:115 Active, 50 Activity ≤ 1 µM, 115 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on